FDA data Registry peer set 1 peer

Alternatives to butorphanol

1 same-class SPL records vs butorphanol - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Stadol

Opioid Agonist-Antagonist Prescription 1 alternative found

About butorphanol

Butorphanol nasal spray is a strong pain medicine. It is used when other pain medicines are not strong enough or cannot be tolerated.

Used for: This medicine treats severe pain that requires an opioid pain reliever. It is for use when other pain treatments are not strong enough or cannot be tolerated. Do not use this medicine for a long time unless your pain is still severe and other treatments are still not adequate.

1 Opioid Agonist-Antagonist peers (wide set)

Compare butorphanol vs nalbuphine side-by-side →

butorphanol vs nalbuphine · FAERS reaction fields

FAERS top-reaction field "Nausea" shows the widest count spread between butorphanol and nalbuphine in this extract (20-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect butorphanol nalbuphine
Drug Hypersensitivity 48 36
Nausea 25 5
Headache 16 5
Pain 16 7
Pruritus 16 6
Vomiting 15 -
Anxiety 14 -
Dyspnoea 14 -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

butorphanol peer mix vs class inventory

Peer mix

0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for Opioid Agonist-Antagonist: 2 drugs.

Frequently Asked Questions

What same-class SPL records sit beside butorphanol?
This registry lists 1 Opioid Agonist-Antagonist medication records beside butorphanol, including nalbuphine. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Opioid Agonist-Antagonist peer set (1 records)

butorphanol (Stadol) sits in a wide Opioid Agonist-Antagonist peer set (1 of 1 class peers shown). Labeled indication field for butorphanol: This medicine treats severe pain that requires an opioid pain reliever.

Top FAERS reaction fields for butorphanol total 190 reports across 10 reactions, set beside nalbuphine. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full butorphanol profile →

Field note for butorphanol: see also the generic vs brand label guide when reading Stadol SPL strings.